Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Pierpaolo Berti"'
Autor:
Giovanni Palladini, Bruno Paiva, Ashutosh Wechalekar, Margherita Massa, Paolo Milani, Marta Lasa, Sriram Ravichandran, Isabel Krsnik, Marco Basset, Leire Burgos, Mario Nuvolone, Ramón Lecumberri, Andrea Foli, Noemi Puig, Melania Antonietta Sesta, Margherita Bozzola, Pasquale Cascino, Alice Nevone, Jessica Ripepi, Pierpaolo Berti, Simona Casarini, Ombretta Annibali, Alberto Orfao, Jesus San-Miguel, Giampaolo Merlini
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 2, Pp 1-7 (2021)
Abstract Light chain (AL) amyloidosis is caused by a small B-cell clone producing light chains that form amyloid deposits and cause organ dysfunction. Chemotherapy aims at suppressing the production of the toxic light chain (LC) and restore organ fun
Externí odkaz:
https://doaj.org/article/1af0c29e396946d49b7a958dc256ed9f
Autor:
Ombretta Annibali, Marta Lasa, Mario Nuvolone, Leire Burgos, Pasquale Cascino, Isabel Krsnik, Sriram Ravichandran, Alice Nevone, Paolo Milani, Andrea Foli, Ashutosh D. Wechalekar, Jesús F. San-Miguel, Margherita Massa, Bruno Paiva, Ramón Lecumberri, Melania Antonietta Sesta, Giampaolo Merlini, Alberto Orfao, Pierpaolo Berti, Marco Basset, Simona Casarini, Margherita Bozzola, Giovanni Palladini, Jessica Ripepi, Noemi Puig
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Blood Cancer Journal, Vol 11, Iss 2, Pp 1-7 (2021)
Blood Cancer Journal
instname
Blood Cancer Journal, Vol 11, Iss 2, Pp 1-7 (2021)
Blood Cancer Journal
© The Author(s) 2021.
Light chain (AL) amyloidosis is caused by a small B-cell clone producing light chains that form amyloid deposits and cause organ dysfunction. Chemotherapy aims at suppressing the production of the toxic light chain (LC) an
Light chain (AL) amyloidosis is caused by a small B-cell clone producing light chains that form amyloid deposits and cause organ dysfunction. Chemotherapy aims at suppressing the production of the toxic light chain (LC) an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e87246b18b34091d1e3d6be6bf093d22
http://hdl.handle.net/10261/261841
http://hdl.handle.net/10261/261841
Autor:
Alessandra Paoloni, Mauro Montanari, Valentina De Nava, Andrea Onetti Muda, Guglielmo Trua, Luisa Strocchio, Costantino Damico, Antonio Cappelli, Francesco Lamura, Alessandra Bernardi, Elisabetta Cicchetti, Maria Teresa Romano, Pierpaolo Berti, Katia Girardi, Laila Costantino
Publikováno v:
Blood. 134:1173-1173
Background: Prophylactic platelet transfusion is commonly used to prevent life-threatening bleeding events in patients with severe thrombocytopenia associated with chemotherapy courses or hematopoietic stem cells transplantation (HSCT). In adults, th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59d471e6515dc45d185ef82dece4a1f9
https://doi.org/10.1182/blood-2019-129132
https://doi.org/10.1182/blood-2019-129132
Autor:
Emanuela Dell'Aquila, Giuseppe Perrone, Marco Caricato, Bruno Vincenzi, Michelina Amato, Francesco Pantano, Francesco Maria Guida, Francesco Graziano, Antonio Russo, Vincenzo Catalano, Daniele Santini, Daniela Righi, Giuseppe Tonini, Andrea Onetti Muda, Sergio Rizzo, Pierpaolo Berti
Publikováno v:
Journal of Cellular and Molecular Medicine
Tumour-associated Macrophages (TAM) present two different polarizations: classical (M1) characterized by immunostimulation activity and tumour suppression; alternative (M2) characterized by tumour promotion and immune suppression. In this retrospecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cec9360ae1d320eb249a9a4d5bc43948
https://doi.org/10.1111/jcmm.12109
https://doi.org/10.1111/jcmm.12109
Autor:
Pierpaolo Berti, Gaia Schiavon, Marco Imperatori, Giuseppe Tonini, Bruno Vincenzi, Daniele Santini, Olga Venditti, Anna Maria Frezza, Francesco Maria Guida
Publikováno v:
Lancet Oncology, 13(10), 1020-1024. Lancet Publishing Group
Itch is a common side-effect of treatment with anti-EGFR antibodies and tyrosine-kinase inhibitors. We designed a pilot single-centre study to assess the effects of aprepitant-a neurokinin receptor inhibitor-for management of severe pruritus induced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d209068b4c1082305956475e2c574aa2
https://pure.eur.nl/en/publications/b621c1af-f2bd-4651-ab50-7bab1e615136
https://pure.eur.nl/en/publications/b621c1af-f2bd-4651-ab50-7bab1e615136
Autor:
Giuseppe Perrone, Salvatore Intagliata, Daniele Santini, F.M. Guida, A. Onetti Muda, Francesco Pantano, Bruno Vincenzi, Francesco Graziano, Pierpaolo Berti, G. Tonini
Introduction Macrophages are one of the major populations of tumor-infiltrating immune cells. Tumor associated Macrophages (TAM) present two different phenotypes or polarizations: classical (M1) characterized by immunostimulation activity and tumor s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61ba8823c84dd6df9101c2a2117d3871
http://hdl.handle.net/11573/1641392
http://hdl.handle.net/11573/1641392
Autor:
Umberto Vespasiani, Pierpaolo Berti, Bruno Vincenzi, Santini Daniele, Anna Maria Frezza, Giuseppe Tonini, Antonio Picardi
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 20(1)
Hepatotoxicity represents a frequent chemotherapy-related side effect, often associated with course delays, discontinuations, and dose reductions. S-adenosylmethionine (AdoMet) administration is effective in the treatment of a variety of liver injuri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee7bc49f03765fa83c2906600715d353
https://pubmed.ncbi.nlm.nih.gov/21229271
https://pubmed.ncbi.nlm.nih.gov/21229271
Autor:
Gaia Schiavon, Pierpaolo Berti, G. Tonini, A.M. Frezza, Marco Imperatori, Bruno Vincenzi, Chiara Spoto, Daniele Santini, Olga Venditti, F.M. Guida
Publikováno v:
Annals of Oncology. 23:ix500-ix501
Introduction Itching is a common dermatologic side effect of anti-epidermal growth factor receptor antibodies and tyrosine kinase inhibitors and may have a dramatic impact on patients' quality of life. Aprepitant, a neurokinin receptor inhibitor, sho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2d4e6758da6399e24b9b9f76195d624
https://doi.org/10.1016/s0923-7534(20)34142-9
https://doi.org/10.1016/s0923-7534(20)34142-9